Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs
Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.